

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 8.68958667 |
| 2 | urate metabolic process (GO:0046415) | 8.59964649 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.43228464 |
| 4 | low-density lipoprotein particle clearance (GO:0034383) | 7.32579875 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.15025404 |
| 6 | drug transport (GO:0015893) | 7.11121960 |
| 7 | lysine metabolic process (GO:0006553) | 6.93138401 |
| 8 | lysine catabolic process (GO:0006554) | 6.93138401 |
| 9 | glyoxylate metabolic process (GO:0046487) | 6.63629815 |
| 10 | phospholipid homeostasis (GO:0055091) | 6.58085101 |
| 11 | drug catabolic process (GO:0042737) | 6.47199396 |
| 12 | phosphate ion transport (GO:0006817) | 6.41495950 |
| 13 | organic cation transport (GO:0015695) | 6.40424227 |
| 14 | exogenous drug catabolic process (GO:0042738) | 6.26650936 |
| 15 | cysteine metabolic process (GO:0006534) | 6.05404317 |
| 16 | quaternary ammonium group transport (GO:0015697) | 5.89739953 |
| 17 | triglyceride catabolic process (GO:0019433) | 5.87849839 |
| 18 | acylglycerol catabolic process (GO:0046464) | 5.62958612 |
| 19 | neutral lipid catabolic process (GO:0046461) | 5.62958612 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.62546316 |
| 21 | L-phenylalanine catabolic process (GO:0006559) | 5.62546316 |
| 22 | short-chain fatty acid metabolic process (GO:0046459) | 5.59714435 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.58306549 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.56907893 |
| 25 | phosphate ion transmembrane transport (GO:0035435) | 5.56740127 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 5.54648795 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.54648795 |
| 28 | fatty acid homeostasis (GO:0055089) | 5.50282766 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.49583798 |
| 30 | plasma lipoprotein particle clearance (GO:0034381) | 5.48472400 |
| 31 | regulation of complement activation (GO:0030449) | 5.43694547 |
| 32 | branched-chain amino acid metabolic process (GO:0009081) | 5.34342521 |
| 33 | low-density lipoprotein particle remodeling (GO:0034374) | 5.31617253 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 5.30483119 |
| 35 | tricarboxylic acid metabolic process (GO:0072350) | 5.27522755 |
| 36 | valine metabolic process (GO:0006573) | 5.25611845 |
| 37 | triglyceride homeostasis (GO:0070328) | 5.13608611 |
| 38 | acylglycerol homeostasis (GO:0055090) | 5.13608611 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 5.03899444 |
| 40 | macromolecular complex remodeling (GO:0034367) | 5.03899444 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 5.03899444 |
| 42 | aromatic amino acid family catabolic process (GO:0009074) | 4.94339468 |
| 43 | response to mercury ion (GO:0046689) | 4.92132291 |
| 44 | aspartate family amino acid catabolic process (GO:0009068) | 4.90254138 |
| 45 | fatty acid beta-oxidation (GO:0006635) | 4.89110972 |
| 46 | regulation of fibrinolysis (GO:0051917) | 4.88834905 |
| 47 | high-density lipoprotein particle remodeling (GO:0034375) | 4.87588467 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.77734474 |
| 49 | branched-chain amino acid catabolic process (GO:0009083) | 4.74455652 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 4.71862888 |
| 51 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.69326661 |
| 52 | regulation of sequestering of triglyceride (GO:0010889) | 4.64670292 |
| 53 | carnitine transport (GO:0015879) | 4.58075289 |
| 54 | amino-acid betaine transport (GO:0015838) | 4.58075289 |
| 55 | fatty acid oxidation (GO:0019395) | 4.54797692 |
| 56 | * diacylglycerol metabolic process (GO:0046339) | 4.49994222 |
| 57 | lipid oxidation (GO:0034440) | 4.49024427 |
| 58 | homocysteine metabolic process (GO:0050667) | 4.43642470 |
| 59 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.39341643 |
| 60 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.39266247 |
| 61 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.39255316 |
| 62 | acetyl-CoA metabolic process (GO:0006084) | 4.37458694 |
| 63 | biotin metabolic process (GO:0006768) | 4.37340697 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 4.34347269 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 4.34188736 |
| 66 | sulfur amino acid catabolic process (GO:0000098) | 4.33821168 |
| 67 | carnitine metabolic process (GO:0009437) | 4.32433259 |
| 68 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.31794813 |
| 69 | protein carboxylation (GO:0018214) | 4.31794813 |
| 70 | indolalkylamine catabolic process (GO:0046218) | 4.30976598 |
| 71 | tryptophan catabolic process (GO:0006569) | 4.30976598 |
| 72 | indole-containing compound catabolic process (GO:0042436) | 4.30976598 |
| 73 | * triglyceride metabolic process (GO:0006641) | 4.29266630 |
| 74 | glutathione biosynthetic process (GO:0006750) | 4.28027904 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 4.27791627 |
| 76 | plasma lipoprotein particle organization (GO:0071827) | 4.25751976 |
| 77 | 2-oxoglutarate metabolic process (GO:0006103) | 4.25643837 |
| 78 | acyl-CoA biosynthetic process (GO:0071616) | 4.24720307 |
| 79 | thioester biosynthetic process (GO:0035384) | 4.24720307 |
| 80 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.24705194 |
| 81 | reverse cholesterol transport (GO:0043691) | 4.23846790 |
| 82 | fatty acid catabolic process (GO:0009062) | 4.21626632 |
| 83 | epoxygenase P450 pathway (GO:0019373) | 4.20754439 |
| 84 | fatty acid transmembrane transport (GO:1902001) | 4.17765170 |
| 85 | omega-hydroxylase P450 pathway (GO:0097267) | 4.16015975 |
| 86 | excretion (GO:0007588) | 4.15805498 |
| 87 | negative regulation of lipase activity (GO:0060192) | 4.15778747 |
| 88 | brown fat cell differentiation (GO:0050873) | 4.11980678 |
| 89 | vitamin D metabolic process (GO:0042359) | 4.11912679 |
| 90 | tryptophan metabolic process (GO:0006568) | 4.11589758 |
| 91 | * acylglycerol metabolic process (GO:0006639) | 4.10650585 |
| 92 | regulation of cholesterol storage (GO:0010885) | 4.07857670 |
| 93 | * triglyceride biosynthetic process (GO:0019432) | 4.06619045 |
| 94 | glycerolipid catabolic process (GO:0046503) | 4.06174980 |
| 95 | cholesterol efflux (GO:0033344) | 4.04930950 |
| 96 | * neutral lipid metabolic process (GO:0006638) | 4.04609878 |
| 97 | * acylglycerol biosynthetic process (GO:0046463) | 4.04110551 |
| 98 | * neutral lipid biosynthetic process (GO:0046460) | 4.04110551 |
| 99 | regulation of cholesterol esterification (GO:0010872) | 4.04080590 |
| 100 | positive regulation of lipid storage (GO:0010884) | 4.02714189 |
| 101 | protein-lipid complex subunit organization (GO:0071825) | 4.00484090 |
| 102 | glutathione derivative biosynthetic process (GO:1901687) | 3.99430796 |
| 103 | glutathione derivative metabolic process (GO:1901685) | 3.99430796 |
| 104 | cellular amino acid catabolic process (GO:0009063) | 3.99138464 |
| 105 | monocarboxylic acid catabolic process (GO:0072329) | 3.94505860 |
| 106 | urea metabolic process (GO:0019627) | 3.92337797 |
| 107 | alpha-amino acid catabolic process (GO:1901606) | 3.91831348 |
| 108 | fructose metabolic process (GO:0006000) | 3.90533236 |
| 109 | plasma lipoprotein particle assembly (GO:0034377) | 3.90001014 |
| 110 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.84747399 |
| 111 | toxin transport (GO:1901998) | 3.83524369 |
| 112 | regulation of apoptotic cell clearance (GO:2000425) | 3.82695234 |
| 113 | acyl-CoA metabolic process (GO:0006637) | 3.81987864 |
| 114 | thioester metabolic process (GO:0035383) | 3.81987864 |
| 115 | glutathione metabolic process (GO:0006749) | 3.79746611 |
| 116 | blood coagulation, intrinsic pathway (GO:0007597) | 3.79439897 |
| 117 | organic acid catabolic process (GO:0016054) | 3.78661794 |
| 118 | carboxylic acid catabolic process (GO:0046395) | 3.78661794 |
| 119 | ketone body metabolic process (GO:1902224) | 3.76548900 |
| 120 | intestinal cholesterol absorption (GO:0030299) | 3.75990051 |
| 121 | drug metabolic process (GO:0017144) | 3.75928489 |
| 122 | glutamate metabolic process (GO:0006536) | 3.72991962 |
| 123 | renal absorption (GO:0070293) | 3.72518742 |
| 124 | negative regulation of sterol transport (GO:0032372) | 3.70800244 |
| 125 | negative regulation of cholesterol transport (GO:0032375) | 3.70800244 |
| 126 | regulation of triglyceride catabolic process (GO:0010896) | 3.70631005 |
| 127 | carnitine shuttle (GO:0006853) | 3.69893942 |
| 128 | proline metabolic process (GO:0006560) | 3.68170957 |
| 129 | alpha-linolenic acid metabolic process (GO:0036109) | 3.64469236 |
| 130 | aromatic amino acid family metabolic process (GO:0009072) | 3.64107124 |
| 131 | uronic acid metabolic process (GO:0006063) | 3.61723001 |
| 132 | glucuronate metabolic process (GO:0019585) | 3.61723001 |
| 133 | negative regulation of protein activation cascade (GO:2000258) | 3.60424682 |
| 134 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.60360433 |
| 135 | NADH metabolic process (GO:0006734) | 3.60345386 |
| 136 | urea cycle (GO:0000050) | 3.56930088 |
| 137 | serine family amino acid biosynthetic process (GO:0009070) | 3.54920431 |
| 138 | metanephric tubule development (GO:0072170) | 3.54895342 |
| 139 | metanephric nephron tubule development (GO:0072234) | 3.54895342 |
| 140 | trivalent inorganic anion homeostasis (GO:0072506) | 3.53835325 |
| 141 | phosphate ion homeostasis (GO:0055062) | 3.53835325 |
| 142 | cholesterol homeostasis (GO:0042632) | 3.52392007 |
| 143 | bile acid biosynthetic process (GO:0006699) | 3.50421820 |
| 144 | acute-phase response (GO:0006953) | 3.50286968 |
| 145 | lipoprotein metabolic process (GO:0042157) | 3.49982383 |
| 146 | NADP metabolic process (GO:0006739) | 3.49900026 |
| 147 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48574322 |
| 148 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48574322 |
| 149 | protein-lipid complex assembly (GO:0065005) | 3.47648887 |
| 150 | phospholipid efflux (GO:0033700) | 3.47542748 |
| 151 | cellular glucuronidation (GO:0052695) | 3.47171244 |
| 152 | nitrogen cycle metabolic process (GO:0071941) | 3.46758207 |
| 153 | sterol homeostasis (GO:0055092) | 3.46156220 |
| 154 | flavonoid metabolic process (GO:0009812) | 3.44749221 |
| 155 | ethanol metabolic process (GO:0006067) | 3.44485927 |
| 156 | ethanol oxidation (GO:0006069) | 3.43752331 |
| 157 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.43236744 |
| 158 | glycoside metabolic process (GO:0016137) | 3.42594240 |
| 159 | peptide biosynthetic process (GO:0043043) | 3.41934428 |
| 160 | kynurenine metabolic process (GO:0070189) | 3.40824230 |
| 161 | succinate metabolic process (GO:0006105) | 3.40343211 |
| 162 | response to phenylpropanoid (GO:0080184) | 3.38709767 |
| 163 | modified amino acid transport (GO:0072337) | 3.36367418 |
| 164 | lipid homeostasis (GO:0055088) | 3.35690744 |
| 165 | alanine transport (GO:0032328) | 3.34698779 |
| 166 | vitamin transport (GO:0051180) | 3.34457461 |
| 167 | fibrinolysis (GO:0042730) | 3.33295227 |
| 168 | L-serine transport (GO:0015825) | 3.30939159 |
| 169 | heme transport (GO:0015886) | 3.30777280 |
| 170 | regulation of cholesterol homeostasis (GO:2000188) | 3.29990246 |
| 171 | small molecule catabolic process (GO:0044282) | 3.29973651 |
| 172 | protein activation cascade (GO:0072376) | 3.29055784 |
| 173 | benzene-containing compound metabolic process (GO:0042537) | 3.27486285 |
| 174 | primary alcohol metabolic process (GO:0034308) | 3.26356984 |
| 175 | sodium-independent organic anion transport (GO:0043252) | 3.25246704 |
| 176 | aldehyde catabolic process (GO:0046185) | 3.24835202 |
| 177 | metanephric nephron epithelium development (GO:0072243) | 3.24566832 |
| 178 | dicarboxylic acid metabolic process (GO:0043648) | 3.23939758 |
| 179 | response to growth hormone (GO:0060416) | 3.22982930 |
| 180 | carnitine transmembrane transport (GO:1902603) | 3.22834411 |
| 181 | tricarboxylic acid cycle (GO:0006099) | 3.16134075 |
| 182 | oxaloacetate metabolic process (GO:0006107) | 3.14142429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.78573182 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.67705580 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.11842025 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.17651776 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.60012599 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 4.06073999 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.47976215 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.26363867 |
| 9 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.08374309 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.89735385 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.69015562 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.64170229 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.46021200 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.35782386 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.26065177 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05113924 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.04697208 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.03076713 |
| 19 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.97340253 |
| 20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.95197982 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88861713 |
| 22 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.88454821 |
| 23 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.79225495 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.66284874 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.64515877 |
| 26 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53037324 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52884437 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.50003010 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47873560 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47642416 |
| 31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.46469824 |
| 32 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45723469 |
| 33 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.36031773 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28372296 |
| 35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.27244436 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25956990 |
| 37 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25442885 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.21355848 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21086543 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17131049 |
| 41 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.16615340 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16337094 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16046095 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13667778 |
| 45 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13659409 |
| 46 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12408939 |
| 47 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11693915 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10232901 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09948423 |
| 50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08562414 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07318562 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07042507 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05967861 |
| 54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05606035 |
| 55 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04812826 |
| 56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03853870 |
| 57 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02305428 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01372346 |
| 59 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01071589 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00351296 |
| 61 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00309202 |
| 62 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.99655808 |
| 63 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97974772 |
| 64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96615647 |
| 65 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95458510 |
| 66 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95360166 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95118895 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94788476 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92402123 |
| 70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.92326406 |
| 71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90393405 |
| 72 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90393405 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90230746 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90019560 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90019560 |
| 76 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87321602 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85480384 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84657856 |
| 79 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83556425 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83190307 |
| 81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82733118 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81507684 |
| 83 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.81313804 |
| 84 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80981725 |
| 85 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80916206 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80828963 |
| 87 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80151278 |
| 88 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79706463 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79447099 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78835750 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78058336 |
| 92 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.77611769 |
| 93 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.77318265 |
| 94 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.76581184 |
| 95 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.76057519 |
| 96 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.74638293 |
| 97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74341464 |
| 98 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72624117 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.70622036 |
| 100 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.70567915 |
| 101 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.69536891 |
| 102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.69206603 |
| 103 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67519848 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67491235 |
| 105 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.66306861 |
| 106 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.65972309 |
| 107 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.65814339 |
| 108 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.65226500 |
| 109 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.65058258 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.64875354 |
| 111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.64710957 |
| 112 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.64633104 |
| 113 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.64610146 |
| 114 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.64510558 |
| 115 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.64451381 |
| 116 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.64110997 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.64027333 |
| 118 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.62299536 |
| 119 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.62276285 |
| 120 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.61050420 |
| 121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.60734710 |
| 122 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.60499052 |
| 123 | CBP_21632823_ChIP-Seq_H3396_Human | 0.60333975 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.60028736 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59959680 |
| 126 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.59707094 |
| 127 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.59541405 |
| 128 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.59108037 |
| 129 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58752071 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58552434 |
| 131 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.58398072 |
| 132 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58380814 |
| 133 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.58335415 |
| 134 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.58217707 |
| 135 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.58142032 |
| 136 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.57421410 |
| 137 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.54287921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.25820085 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.22537406 |
| 3 | MP0004043_abnormal_pH_regulation | 4.55951028 |
| 4 | MP0005332_abnormal_amino_acid | 4.43777847 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 4.22378082 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.73158690 |
| 7 | MP0005365_abnormal_bile_salt | 3.70982316 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.49057400 |
| 9 | MP0009643_abnormal_urine_homeostasis | 3.22897298 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 3.18468717 |
| 11 | MP0008004_abnormal_stomach_pH | 3.07147564 |
| 12 | MP0003195_calcinosis | 3.00948160 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 3.00412988 |
| 14 | MP0001765_abnormal_ion_homeostasis | 2.75747211 |
| 15 | MP0003252_abnormal_bile_duct | 2.72502406 |
| 16 | MP0005636_abnormal_mineral_homeostasis | 2.52971148 |
| 17 | MP0001756_abnormal_urination | 2.44824495 |
| 18 | MP0003011_delayed_dark_adaptation | 2.42292283 |
| 19 | MP0002136_abnormal_kidney_physiology | 2.22399996 |
| 20 | MP0003186_abnormal_redox_activity | 2.14571515 |
| 21 | MP0005670_abnormal_white_adipose | 2.10217277 |
| 22 | MP0010329_abnormal_lipoprotein_level | 2.05900683 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.97705303 |
| 24 | MP0003878_abnormal_ear_physiology | 1.94977959 |
| 25 | MP0005377_hearing/vestibular/ear_phenot | 1.94977959 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.85325894 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.83963012 |
| 28 | MP0004272_abnormal_basement_membrane | 1.81851393 |
| 29 | MP0006054_spinal_hemorrhage | 1.74501715 |
| 30 | MP0001958_emphysema | 1.72365403 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.69984408 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.69576975 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.66615540 |
| 34 | MP0005448_abnormal_energy_balance | 1.63463645 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.62987833 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.49337088 |
| 37 | MP0005083_abnormal_biliary_tract | 1.35626142 |
| 38 | MP0005451_abnormal_body_composition | 1.33643539 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.33294995 |
| 40 | MP0004885_abnormal_endolymph | 1.33091217 |
| 41 | MP0002254_reproductive_system_inflammat | 1.31888469 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.27502224 |
| 43 | MP0005535_abnormal_body_temperature | 1.27379399 |
| 44 | MP0001661_extended_life_span | 1.24454243 |
| 45 | MP0000609_abnormal_liver_physiology | 1.23349327 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.21168344 |
| 47 | MP0010368_abnormal_lymphatic_system | 1.21063849 |
| 48 | MP0001881_abnormal_mammary_gland | 1.20702445 |
| 49 | MP0001764_abnormal_homeostasis | 1.16770006 |
| 50 | MP0005164_abnormal_response_to | 1.16080916 |
| 51 | MP0003828_pulmonary_edema | 1.15903125 |
| 52 | MP0002132_abnormal_respiratory_system | 1.15083552 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.10456300 |
| 54 | MP0001664_abnormal_digestion | 1.08648593 |
| 55 | MP0000538_abnormal_urinary_bladder | 1.07006763 |
| 56 | MP0006138_congestive_heart_failure | 1.04022889 |
| 57 | MP0001915_intracranial_hemorrhage | 1.03547187 |
| 58 | MP0000230_abnormal_systemic_arterial | 0.99867693 |
| 59 | MP0005647_abnormal_sex_gland | 0.98254953 |
| 60 | MP0002168_other_aberrant_phenotype | 0.97781564 |
| 61 | MP0003950_abnormal_plasma_membrane | 0.97196284 |
| 62 | MP0004130_abnormal_muscle_cell | 0.96788447 |
| 63 | MP0009840_abnormal_foam_cell | 0.94591324 |
| 64 | MP0003300_gastrointestinal_ulcer | 0.93717658 |
| 65 | MP0003941_abnormal_skin_development | 0.93277652 |
| 66 | MP0005375_adipose_tissue_phenotype | 0.92293579 |
| 67 | MP0004264_abnormal_extraembryonic_tissu | 0.91487570 |
| 68 | MP0002971_abnormal_brown_adipose | 0.87665042 |
| 69 | MP0004147_increased_porphyrin_level | 0.87329044 |
| 70 | MP0009642_abnormal_blood_homeostasis | 0.86700125 |
| 71 | MP0004883_abnormal_blood_vessel | 0.85229968 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.81214738 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 0.80271219 |
| 74 | MP0002928_abnormal_bile_duct | 0.78718402 |
| 75 | MP0000003_abnormal_adipose_tissue | 0.77555178 |
| 76 | MP0009763_increased_sensitivity_to | 0.76413839 |
| 77 | MP0002796_impaired_skin_barrier | 0.76042824 |
| 78 | MP0000598_abnormal_liver_morphology | 0.75988660 |
| 79 | MP0003959_abnormal_lean_body | 0.75178694 |
| 80 | MP0009764_decreased_sensitivity_to | 0.75038598 |
| 81 | MP0003638_abnormal_response/metabolism_ | 0.73703085 |
| 82 | MP0003633_abnormal_nervous_system | 0.73535610 |
| 83 | MP0003690_abnormal_glial_cell | 0.72572756 |
| 84 | MP0002135_abnormal_kidney_morphology | 0.71682548 |
| 85 | MP0005165_increased_susceptibility_to | 0.70363626 |
| 86 | MP0010234_abnormal_vibrissa_follicle | 0.68975686 |
| 87 | MP0001851_eye_inflammation | 0.68844763 |
| 88 | MP0005334_abnormal_fat_pad | 0.68280798 |
| 89 | MP0003329_amyloid_beta_deposits | 0.68092211 |
| 90 | MP0003953_abnormal_hormone_level | 0.66769021 |
| 91 | MP0000343_altered_response_to | 0.65992673 |
| 92 | MP0005408_hypopigmentation | 0.63046042 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.60785147 |
| 94 | MP0005330_cardiomyopathy | 0.60080360 |
| 95 | MP0000249_abnormal_blood_vessel | 0.60035677 |
| 96 | MP0008469_abnormal_protein_level | 0.59897766 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.58352535 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.58171803 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.57098412 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.57050436 |
| 101 | MP0003724_increased_susceptibility_to | 0.55912366 |
| 102 | MP0004484_altered_response_of | 0.54895487 |
| 103 | MP0000747_muscle_weakness | 0.54409934 |
| 104 | MP0003705_abnormal_hypodermis_morpholog | 0.54244147 |
| 105 | MP0009115_abnormal_fat_cell | 0.53141746 |
| 106 | MP0003566_abnormal_cell_adhesion | 0.52950684 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.52723503 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.52723503 |
| 109 | MP0008438_abnormal_cutaneous_collagen | 0.52697092 |
| 110 | MP0005266_abnormal_metabolism | 0.52282887 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.51098149 |
| 112 | MP0003868_abnormal_feces_composition | 0.51051131 |
| 113 | MP0005376_homeostasis/metabolism_phenot | 0.50878154 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.50767752 |
| 115 | MP0005395_other_phenotype | 0.50083809 |
| 116 | MP0002089_abnormal_postnatal_growth/wei | 0.49962743 |
| 117 | MP0003948_abnormal_gas_homeostasis | 0.49182143 |
| 118 | MP0001879_abnormal_lymphatic_vessel | 0.48531312 |
| 119 | MP0001663_abnormal_digestive_system | 0.48385549 |
| 120 | MP0000604_amyloidosis | 0.47294581 |
| 121 | MP0000470_abnormal_stomach_morphology | 0.46605521 |
| 122 | MP0002972_abnormal_cardiac_muscle | 0.46552019 |
| 123 | MP0003075_altered_response_to | 0.46491694 |
| 124 | MP0002069_abnormal_eating/drinking_beha | 0.45660279 |
| 125 | MP0001485_abnormal_pinna_reflex | 0.45264944 |
| 126 | MP0002160_abnormal_reproductive_system | 0.44863544 |
| 127 | MP0000920_abnormal_myelination | 0.44751634 |
| 128 | MP0002970_abnormal_white_adipose | 0.43073379 |
| 129 | MP0005452_abnormal_adipose_tissue | 0.42417984 |
| 130 | MP0003646_muscle_fatigue | 0.41988951 |
| 131 | MP0004858_abnormal_nervous_system | 0.41962695 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.41506751 |
| 133 | MP0010386_abnormal_urinary_bladder | 0.41350592 |
| 134 | MP0003631_nervous_system_phenotype | 0.40637047 |
| 135 | MP0001873_stomach_inflammation | 0.38869043 |
| 136 | MP0009672_abnormal_birth_weight | 0.38019573 |
| 137 | MP0008872_abnormal_physiological_respon | 0.37372229 |
| 138 | MP0004742_abnormal_vestibular_system | 0.37279833 |
| 139 | MP0002938_white_spotting | 0.37275440 |
| 140 | MP0005501_abnormal_skin_physiology | 0.36905027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 7.88240787 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.83391860 |
| 3 | Hyperlipoproteinemia (HP:0010980) | 7.64108034 |
| 4 | Gout (HP:0001997) | 6.57293587 |
| 5 | Increased circulating renin level (HP:0000848) | 6.18869264 |
| 6 | Abnormality of complement system (HP:0005339) | 6.06643451 |
| 7 | Hypokalemic alkalosis (HP:0001949) | 5.97437264 |
| 8 | Metabolic alkalosis (HP:0200114) | 5.77728841 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.59455666 |
| 10 | Hyperglycinuria (HP:0003108) | 5.48057494 |
| 11 | Hyperactive renin-angiotensin system (HP:0000841) | 5.32802296 |
| 12 | Hypomagnesemia (HP:0002917) | 5.30695667 |
| 13 | Polyuria (HP:0000103) | 5.18392917 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 5.16878794 |
| 15 | Proximal tubulopathy (HP:0000114) | 5.15265416 |
| 16 | Abnormality of chloride homeostasis (HP:0011422) | 5.12095940 |
| 17 | Abnormal urine output (HP:0012590) | 5.01916097 |
| 18 | Epidermoid cyst (HP:0200040) | 4.97894791 |
| 19 | Abnormality of renal excretion (HP:0011036) | 4.90268120 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 4.80694457 |
| 21 | Hyperuricemia (HP:0002149) | 4.79215292 |
| 22 | Increased purine levels (HP:0004368) | 4.79215292 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.74097616 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.68810659 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.68810659 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.63926493 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 4.63907796 |
| 28 | Hypercholesterolemia (HP:0003124) | 4.55265326 |
| 29 | Ketoacidosis (HP:0001993) | 4.52161579 |
| 30 | Glomerulonephritis (HP:0000099) | 4.42534512 |
| 31 | Abnormality of magnesium homeostasis (HP:0004921) | 4.42506140 |
| 32 | Spontaneous abortion (HP:0005268) | 4.38741307 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 4.37384234 |
| 34 | Joint hemorrhage (HP:0005261) | 4.36330395 |
| 35 | Ketosis (HP:0001946) | 4.29518368 |
| 36 | Generalized aminoaciduria (HP:0002909) | 4.15045519 |
| 37 | Alkalosis (HP:0001948) | 4.14646145 |
| 38 | Abnormal drinking behavior (HP:0030082) | 4.03102574 |
| 39 | Polydipsia (HP:0001959) | 4.03102574 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 3.95631498 |
| 41 | Renal salt wasting (HP:0000127) | 3.90233868 |
| 42 | Hemorrhage of the eye (HP:0011885) | 3.76726507 |
| 43 | Abnormality of renin-angiotensin system (HP:0000847) | 3.76233813 |
| 44 | Glycosuria (HP:0003076) | 3.74456832 |
| 45 | Abnormality of urine glucose concentration (HP:0011016) | 3.74456832 |
| 46 | Hyperglycinemia (HP:0002154) | 3.68674760 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66478467 |
| 48 | Hyperaldosteronism (HP:0000859) | 3.65416934 |
| 49 | Tetany (HP:0001281) | 3.53376973 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 3.48680223 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.44836538 |
| 52 | Hyperammonemia (HP:0001987) | 3.44138676 |
| 53 | Myocardial infarction (HP:0001658) | 3.41383697 |
| 54 | Hypolipoproteinemia (HP:0010981) | 3.40386403 |
| 55 | Skin nodule (HP:0200036) | 3.39291977 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.35889852 |
| 57 | Rhabdomyolysis (HP:0003201) | 3.32508030 |
| 58 | Hypercalciuria (HP:0002150) | 3.23862995 |
| 59 | Renal tubular acidosis (HP:0001947) | 3.17501321 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.16482137 |
| 61 | Increased serum pyruvate (HP:0003542) | 3.13606577 |
| 62 | Hyperphosphaturia (HP:0003109) | 3.12814877 |
| 63 | Hydroxyprolinuria (HP:0003080) | 3.10138486 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 3.10138486 |
| 65 | Vascular calcification (HP:0004934) | 3.06194699 |
| 66 | Nephritis (HP:0000123) | 3.05041317 |
| 67 | Delayed CNS myelination (HP:0002188) | 3.03905967 |
| 68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.95832446 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.95832446 |
| 70 | Abnormal urine phosphate concentration (HP:0012599) | 2.93171012 |
| 71 | Xanthomatosis (HP:0000991) | 2.89443507 |
| 72 | Small epiphyses (HP:0010585) | 2.83217205 |
| 73 | Hypoalphalipoproteinemia (HP:0003233) | 2.82325059 |
| 74 | Abnormality of glycolysis (HP:0004366) | 2.80972601 |
| 75 | Hypokalemia (HP:0002900) | 2.80610617 |
| 76 | Myoglobinuria (HP:0002913) | 2.77853819 |
| 77 | Intrahepatic cholestasis (HP:0001406) | 2.76255392 |
| 78 | Metabolic acidosis (HP:0001942) | 2.75137543 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.74404149 |
| 80 | Nephrolithiasis (HP:0000787) | 2.69421015 |
| 81 | Lethargy (HP:0001254) | 2.64033939 |
| 82 | Hypertriglyceridemia (HP:0002155) | 2.62727274 |
| 83 | Rickets (HP:0002748) | 2.61864408 |
| 84 | Vomiting (HP:0002013) | 2.61553617 |
| 85 | Confusion (HP:0001289) | 2.59622332 |
| 86 | Delayed epiphyseal ossification (HP:0002663) | 2.56464627 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 2.53958616 |
| 88 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.52093097 |
| 89 | Hypophosphatemia (HP:0002148) | 2.51791775 |
| 90 | Fat malabsorption (HP:0002630) | 2.50243017 |
| 91 | Abnormality of the intrinsic pathway (HP:0010989) | 2.48569426 |
| 92 | Abnormality of potassium homeostasis (HP:0011042) | 2.47011367 |
| 93 | Abnormality of methionine metabolism (HP:0010901) | 2.46517701 |
| 94 | Nephrocalcinosis (HP:0000121) | 2.45429334 |
| 95 | Malnutrition (HP:0004395) | 2.44042124 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.39253450 |
| 97 | Abnormality of carpal bone ossification (HP:0006257) | 2.37218875 |
| 98 | Enlarged kidneys (HP:0000105) | 2.33982620 |
| 99 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.33679962 |
| 100 | Hypoglycemic coma (HP:0001325) | 2.29297098 |
| 101 | Methylmalonic aciduria (HP:0012120) | 2.28397493 |
| 102 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.27967802 |
| 103 | Mitral stenosis (HP:0001718) | 2.27614997 |
| 104 | Dehydration (HP:0001944) | 2.25325798 |
| 105 | Abnormality of serum amino acid levels (HP:0003112) | 2.24938989 |
| 106 | Widely patent fontanelles and sutures (HP:0004492) | 2.24483498 |
| 107 | Hepatocellular carcinoma (HP:0001402) | 2.23186091 |
| 108 | Abnormal tarsal ossification (HP:0008369) | 2.20797013 |
| 109 | Sensorimotor neuropathy (HP:0007141) | 2.20107388 |
| 110 | Metaphyseal cupping (HP:0003021) | 2.19855370 |
| 111 | Flat acetabular roof (HP:0003180) | 2.16676062 |
| 112 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.15437317 |
| 113 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.14254147 |
| 114 | Abnormality of renal resorption (HP:0011038) | 2.12783853 |
| 115 | Hypophosphatemic rickets (HP:0004912) | 2.11448870 |
| 116 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.10518251 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 2.08960185 |
| 118 | Renal tubular dysfunction (HP:0000124) | 2.06812908 |
| 119 | Tubulointerstitial fibrosis (HP:0005576) | 2.04795066 |
| 120 | Abnormal delivery (HP:0001787) | 2.04631544 |
| 121 | Irritability (HP:0000737) | 2.03665663 |
| 122 | Nausea (HP:0002018) | 2.01449610 |
| 123 | Purpura (HP:0000979) | 2.00629513 |
| 124 | Thrombophlebitis (HP:0004418) | 2.00399781 |
| 125 | Oligomenorrhea (HP:0000876) | 1.99616139 |
| 126 | Abnormality of vitamin B metabolism (HP:0004340) | 1.98660148 |
| 127 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.97426475 |
| 128 | Gingival bleeding (HP:0000225) | 1.95340864 |
| 129 | Pigmentary retinal degeneration (HP:0001146) | 1.94759560 |
| 130 | Visceral angiomatosis (HP:0100761) | 1.94005298 |
| 131 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.91884269 |
| 132 | Megaloblastic anemia (HP:0001889) | 1.90910138 |
| 133 | Hemangiomatosis (HP:0007461) | 1.89482824 |
| 134 | Neonatal onset (HP:0003623) | 1.89466182 |
| 135 | Facial shape deformation (HP:0011334) | 1.88351020 |
| 136 | Potter facies (HP:0002009) | 1.88351020 |
| 137 | Spastic diplegia (HP:0001264) | 1.88303619 |
| 138 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87187855 |
| 139 | Abnormality of alanine metabolism (HP:0010916) | 1.87187855 |
| 140 | Hyperalaninemia (HP:0003348) | 1.87187855 |
| 141 | Reduced antithrombin III activity (HP:0001976) | 1.86666269 |
| 142 | Esophageal varix (HP:0002040) | 1.85903036 |
| 143 | Lymphangioma (HP:0100764) | 1.83329885 |
| 144 | Subcapsular cataract (HP:0000523) | 1.83099693 |
| 145 | Hyponatremia (HP:0002902) | 1.81440161 |
| 146 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.81337867 |
| 147 | Axonal loss (HP:0003447) | 1.80862342 |
| 148 | Late onset (HP:0003584) | 1.80478589 |
| 149 | Abnormality of sodium homeostasis (HP:0010931) | 1.80280921 |
| 150 | Tachypnea (HP:0002789) | 1.79923674 |
| 151 | Pancreatitis (HP:0001733) | 1.79278156 |
| 152 | Elevated alkaline phosphatase (HP:0003155) | 1.78935711 |
| 153 | Abnormal hand bone ossification (HP:0010660) | 1.78578588 |
| 154 | Abnormality of vitamin metabolism (HP:0100508) | 1.78561972 |
| 155 | Acanthosis nigricans (HP:0000956) | 1.77812973 |
| 156 | Glomerulosclerosis (HP:0000096) | 1.77509050 |
| 157 | Back pain (HP:0003418) | 1.77355374 |
| 158 | Cupped ribs (HP:0000887) | 1.76434316 |
| 159 | Abnormality of the periventricular white matter (HP:0002518) | 1.73646075 |
| 160 | Abnormal pupillary function (HP:0007686) | 1.73030344 |
| 161 | Cerebral palsy (HP:0100021) | 1.71507769 |
| 162 | Prenatal maternal abnormality (HP:0002686) | 1.68374063 |
| 163 | Steatorrhea (HP:0002570) | 1.67920697 |
| 164 | Cholelithiasis (HP:0001081) | 1.65271944 |
| 165 | Abnormal ossification of hand bones (HP:0005921) | 1.64554380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 8.02060704 |
| 2 | OXSR1 | 6.29237457 |
| 3 | WNK3 | 5.95777482 |
| 4 | BCKDK | 5.01355166 |
| 5 | STK39 | 4.45765387 |
| 6 | FGFR3 | 2.78602290 |
| 7 | MST1R | 2.50220650 |
| 8 | AKT3 | 2.46828599 |
| 9 | PDK3 | 2.45978599 |
| 10 | PDK4 | 2.45978599 |
| 11 | EPHA3 | 2.42130114 |
| 12 | NLK | 2.40428885 |
| 13 | STK38L | 2.29864598 |
| 14 | PIK3CA | 2.29254232 |
| 15 | BMPR1B | 2.21478890 |
| 16 | MST4 | 2.08239038 |
| 17 | PBK | 1.85341146 |
| 18 | PDGFRA | 1.83585768 |
| 19 | WNK1 | 1.80636235 |
| 20 | SGK223 | 1.78995162 |
| 21 | SGK494 | 1.78995162 |
| 22 | DDR2 | 1.76793755 |
| 23 | JAK1 | 1.71826453 |
| 24 | PDK2 | 1.66875585 |
| 25 | NEK1 | 1.61931367 |
| 26 | MAPKAPK3 | 1.59391394 |
| 27 | NTRK3 | 1.54331741 |
| 28 | ERBB4 | 1.48007556 |
| 29 | ICK | 1.41269200 |
| 30 | TRIM28 | 1.32182512 |
| 31 | FGFR1 | 1.31967102 |
| 32 | FGFR4 | 1.26721602 |
| 33 | SIK3 | 1.24978070 |
| 34 | RET | 1.22449195 |
| 35 | TRIB3 | 1.19861836 |
| 36 | PIM2 | 1.16982209 |
| 37 | SIK1 | 1.14793457 |
| 38 | STK38 | 1.14257557 |
| 39 | TYK2 | 1.13117264 |
| 40 | LRRK2 | 1.08238521 |
| 41 | EIF2AK3 | 1.06995671 |
| 42 | ERN1 | 1.06900936 |
| 43 | MET | 1.05877167 |
| 44 | MAPKAPK5 | 1.02252351 |
| 45 | MAP3K5 | 1.01918803 |
| 46 | PIM1 | 1.01120739 |
| 47 | ACVR1B | 0.98670498 |
| 48 | CAMK1G | 0.97274428 |
| 49 | OBSCN | 0.95372973 |
| 50 | BMPR2 | 0.93601518 |
| 51 | FLT3 | 0.93352690 |
| 52 | SGK3 | 0.92063467 |
| 53 | LATS1 | 0.90859524 |
| 54 | TYRO3 | 0.86420870 |
| 55 | EPHB1 | 0.86355744 |
| 56 | SGK2 | 0.85395060 |
| 57 | GSK3A | 0.84693419 |
| 58 | INSRR | 0.83868748 |
| 59 | PRKAA2 | 0.83603731 |
| 60 | PINK1 | 0.82152718 |
| 61 | PDGFRB | 0.80712340 |
| 62 | MAP3K3 | 0.80542063 |
| 63 | CDC42BPA | 0.76167566 |
| 64 | CDK4 | 0.75140569 |
| 65 | FRK | 0.74937560 |
| 66 | GRK6 | 0.72856544 |
| 67 | CAMK1D | 0.72640768 |
| 68 | PDPK1 | 0.71776820 |
| 69 | ABL2 | 0.67976209 |
| 70 | PRKAA1 | 0.65215900 |
| 71 | SRPK1 | 0.63342306 |
| 72 | PIK3CG | 0.63208250 |
| 73 | CAMK1 | 0.62580591 |
| 74 | ERBB2 | 0.61537203 |
| 75 | MYLK | 0.61259847 |
| 76 | CDK9 | 0.61040792 |
| 77 | PTK6 | 0.60597130 |
| 78 | ERBB3 | 0.59563306 |
| 79 | MAPK11 | 0.58817096 |
| 80 | MAP3K7 | 0.58609743 |
| 81 | PTK2 | 0.54840785 |
| 82 | SGK1 | 0.51332577 |
| 83 | MTOR | 0.49724788 |
| 84 | PAK3 | 0.47512866 |
| 85 | FER | 0.47440030 |
| 86 | PAK2 | 0.46720692 |
| 87 | TIE1 | 0.46653489 |
| 88 | PDK1 | 0.46558355 |
| 89 | MAPK3 | 0.46546716 |
| 90 | CAMKK2 | 0.44626487 |
| 91 | GRK7 | 0.42050712 |
| 92 | RIPK1 | 0.41623703 |
| 93 | MAP2K4 | 0.40334650 |
| 94 | NEK6 | 0.40073749 |
| 95 | DYRK1B | 0.38472932 |
| 96 | PRKG1 | 0.37600194 |
| 97 | MAP3K2 | 0.37410173 |
| 98 | PRKCZ | 0.37308321 |
| 99 | TGFBR2 | 0.37215973 |
| 100 | LMTK2 | 0.37106086 |
| 101 | GRK1 | 0.35892507 |
| 102 | NTRK1 | 0.35304556 |
| 103 | IRAK2 | 0.35163225 |
| 104 | MAP2K3 | 0.34888897 |
| 105 | STK10 | 0.34581476 |
| 106 | RPS6KA3 | 0.34538054 |
| 107 | MAP2K1 | 0.33664529 |
| 108 | PRKACB | 0.32777645 |
| 109 | TTK | 0.31876425 |
| 110 | PRKACG | 0.31828732 |
| 111 | BMX | 0.30029208 |
| 112 | CSNK1G2 | 0.29907156 |
| 113 | MELK | 0.28632951 |
| 114 | FGFR2 | 0.28574395 |
| 115 | PRKCI | 0.28487493 |
| 116 | STK3 | 0.28193325 |
| 117 | EPHA4 | 0.27527239 |
| 118 | BCR | 0.27226141 |
| 119 | PTK2B | 0.27223414 |
| 120 | ROCK1 | 0.26728630 |
| 121 | RPS6KB1 | 0.26720039 |
| 122 | JAK2 | 0.26230407 |
| 123 | PNCK | 0.23980021 |
| 124 | CSNK1G1 | 0.23827967 |
| 125 | NEK9 | 0.21625559 |
| 126 | MAPK12 | 0.20894782 |
| 127 | MAP2K2 | 0.20817296 |
| 128 | PKN2 | 0.20240464 |
| 129 | AKT2 | 0.19492128 |
| 130 | KSR2 | 0.19227308 |
| 131 | NME2 | 0.19048214 |
| 132 | MAPK15 | 0.18776409 |
| 133 | MINK1 | 0.18733603 |
| 134 | PRKCD | 0.18654639 |
| 135 | PRKACA | 0.18090355 |
| 136 | PRKCA | 0.18081821 |
| 137 | EPHB2 | 0.17767956 |
| 138 | IGF1R | 0.16460947 |
| 139 | STK11 | 0.15928074 |
| 140 | LATS2 | 0.15310671 |
| 141 | PRKCQ | 0.15262208 |
| 142 | CSK | 0.15161945 |
| 143 | PRKD2 | 0.13741302 |
| 144 | SRC | 0.13521427 |
| 145 | PAK4 | 0.13017805 |
| 146 | ROCK2 | 0.12123385 |
| 147 | MAPK4 | 0.11659518 |
| 148 | INSR | 0.11074211 |
| 149 | PRKCH | 0.10298554 |
| 150 | CDK6 | 0.09621082 |
| 151 | FYN | 0.09613325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.46648985 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.26287731 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.25768717 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.22391512 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.06318113 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.04420697 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.74405698 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.70624807 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69704506 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.49033130 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.43843882 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.41010645 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.32027835 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.24741583 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.21609296 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.21233295 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.16642078 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.05341746 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.02468884 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00967781 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.00249795 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99723273 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.94342488 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.92896873 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.86377845 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82550005 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.64067114 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.63768575 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.60023215 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.57880738 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.54946374 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.52526982 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37282867 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36083935 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23621432 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23502088 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23008599 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.22583858 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20867630 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18639333 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12529556 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05369508 |
| 43 | Lysine degradation_Homo sapiens_hsa00310 | 1.00353054 |
| 44 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98797414 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97035415 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96661455 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92905691 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90614639 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90426962 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.85225324 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84831993 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83077208 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77326407 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76076769 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75940655 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75234848 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74267280 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72607791 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70167066 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69580112 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67870449 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67312382 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.67293784 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66601919 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64029303 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60766384 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60130684 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54050009 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53931299 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.52737858 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52278889 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47296423 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47007963 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44145660 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41148236 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40026107 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39568679 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38424228 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.37769709 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.36288903 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36171986 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35967024 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35391717 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34915148 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33068996 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29310496 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26876578 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.22649855 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20655291 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.20552307 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18246791 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16269978 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.15727735 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14239396 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.13668933 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.11890407 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.11604408 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10518922 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.08542140 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05032236 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.04789756 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.04317170 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.04106390 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.03111315 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.01745914 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.01422450 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.00239213 |
| 108 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.1717793 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1286539 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1268454 |
| 111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1165268 |
| 112 | Malaria_Homo sapiens_hsa05144 | -0.0640188 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | -0.0382442 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0191558 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0150800 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0125974 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0063616 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0040828 |

